Clinical Research Directory

Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy

Sponsor: CARsgen Therapeutics Co., Ltd.

Summary

This is a prospective long-term follow-up (LTFU) study to evaluate the long-term safety and survival benefit for patients who received at least one of CARsgen's GM T cell product in a clinical trial or as a commercially available product. In this study, patients will be followed for up to 15 years after last GM T-cell infusion for the evaluation of delayed adverse events (AEs), vector persistence, potential risk for integration, and survival time due to GM T-cell exposure.

Key Details

Conditions

Interventions